NewAmsterdam Pharma Company N.V.
← Back to NAMSW Overview

NewAmsterdam Pharma Company N.V. (NAMSW)

Solvency & Capital Structure

Total Debt

$202K

Net Debt

-$636M

NewAmsterdam Pharma Company N.V. currently has $202K in total debt. Net debt is -$636M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

NAMSWQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2025-12-310.000.64-0.64Net Cash0.770.0%
2025-09-300.000.70-0.70Net Cash0.790.0%
2025-06-300.000.74-0.74Net Cash0.820.0%
2025-03-310.000.81-0.81Net Cash0.820.0%
2024-12-310.000.83-0.83Net Cash0.860.1%
2024-09-300.000.42-0.42Net Cash0.440.1%
2024-06-300.000.43-0.43Net Cash0.450.1%
2024-03-310.000.48-0.48Net Cash0.490.0%
2023-12-310.000.34-0.34Net Cash0.350.0%
2023-06-300.000.42-0.42Net Cash0.510.0%
2022-12-310.000.47-0.47Net Cash0.480.0%
2022-09-300.000.47-0.47Net Cash0.480.0%
2022-06-300.000.09-0.09Net Cash0.230.1%
2022-03-310.000.00-0.00Net Cash0.130.0%
2021-12-310.000.06-0.06Net Cash0.070.3%
2021-09-300.000.00-0.00Net Cash0.140.0%
2021-06-300.000.00-0.00Net Cash0.140.0%
2021-03-310.000.00-0.00Net Cash0.140.0%
2020-12-310.000.00-0.00Net Cash0.140.0%
2020-09-300.000.000.000.00126.2%
2020-06-300.000.000.000.00126.2%
2020-03-310.000.000.000.00126.2%